Suppr超能文献

深入了解β-淀粉样蛋白(1-42)肽自我聚集的动力学:阐明抑制剂的作用机制。

Insight into the kinetic of amyloid beta (1-42) peptide self-aggregation: elucidation of inhibitors' mechanism of action.

作者信息

Bartolini Manuela, Bertucci Carlo, Bolognesi Maria Laura, Cavalli Andrea, Melchiorre Carlo, Andrisano Vincenza

机构信息

Department of Pharmaceutical Sciences, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy.

出版信息

Chembiochem. 2007 Nov 23;8(17):2152-61. doi: 10.1002/cbic.200700427.

Abstract

The initial transition of amyloid beta (1-42) (Abeta42) soluble monomers/small oligomers from unordered/alpha-helix to a beta-sheet-rich conformation represents a suitable target to design new potent inhibitors and to obtain effective therapeutics for Alzheimer's disease. Under optimized conditions, this reliable and reproducible CD kinetic study showed a three-step sigmoid profile that was characterized by a lag phase (prevailing unordered/alpha-helix conformation), an exponential growth phase (increasing beta-sheet secondary structure) and a plateau phase (prevailing beta-sheet secondary structure). This kinetic analysis brought insight into the inhibitors' mechanism of action. In fact, an increase in the duration of the lag phase can be related to the formation of an inhibitor-Abeta complex, in which the non-amyloidogenic conformation is stabilized. When the exponential rate is affected exclusively, such as in the case of Congo red and tetracycline, then the inhibitor affinity might be higher for the pleated beta-sheet structure. Finally, by adding the inhibitor at the end of the exponential phase, the soluble protofibrils can be disrupted and the Abeta amyloidogenic structure can revert into monomers/small oligomers. Congo red and tetracycline preferentially bind to amyloid in the beta-sheet conformation because both decreased the slope of the exponential growth, even if to a different extent, whereas no effect was observed for tacrine and galantamine. Some very preliminary indications can be derived about the structural requirements for binding to nonamyloidogenic or beta-sheet amyloid secondary structure for the development of potent antiaggregating agents. On these premises, memoquin, a multifunctional molecule that was designed to become a drug candidate for the treatment of Alzheimer's disease, was investigated under the reported circular dichroism assay and its anti-amyloidogenic mechanism of action was elucidated.

摘要

淀粉样β蛋白(1-42)(Aβ42)可溶性单体/小寡聚体从无序/α-螺旋向富含β-折叠构象的初始转变,是设计新型强效抑制剂以及获得阿尔茨海默病有效治疗方法的合适靶点。在优化条件下,这项可靠且可重复的圆二色性动力学研究显示出一个三步的S形曲线,其特征为一个延迟期(主要为无序/α-螺旋构象)、一个指数增长期(β-折叠二级结构增加)和一个平台期(主要为β-折叠二级结构)。这种动力学分析深入了解了抑制剂的作用机制。事实上,延迟期持续时间的增加可能与抑制剂 - Aβ复合物的形成有关,其中非淀粉样生成构象得以稳定。当仅指数速率受到影响时,如刚果红和四环素的情况,那么抑制剂对褶皱β-折叠结构的亲和力可能更高。最后,在指数期结束时添加抑制剂,可以破坏可溶性原纤维,并且Aβ淀粉样生成结构可以恢复为单体/小寡聚体。刚果红和四环素优先结合β-折叠构象的淀粉样蛋白,因为两者都降低了指数增长的斜率,尽管程度不同,而他克林和加兰他敏则未观察到效果。关于开发强效抗聚集剂与非淀粉样生成或β-折叠淀粉样二级结构结合的结构要求,可以得出一些非常初步的迹象。在此前提下,在报道的圆二色性测定中研究了旨在成为治疗阿尔茨海默病候选药物的多功能分子美金刚胺,并阐明了其抗淀粉样生成的作用机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验